Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 37 No. 47, November 23, 2011 issue of the Florida Administrative Weekly.

The change is in response to written comments submitted by the staff of the Joint Administrative Procedures Committee. Changes are being made to the various forms to address multiple comments from JAPC, including technical and substantive changes. Changes have also been made to the forms as a result of legislative changes to Section 465.0635, F.S. The changes are as follows:

1. The revision date of Form DH-MQA 1214, “Community Pharmacy Permit and Application and Information” incorporated by reference in subsection (2) will be updated to have an effective date of August 2012.

2. (2)(c) shall now read as follows:

(c) The policy and procedure manual for Community Pharmacies shall contain the procedures implemented to minimize the dispensing of controlled substances based on fraudulent representations. The policy and procedural manual shall provide the following:

3. There will be no changes to (2)(c)1. through 4., as published in the Notice of Change for the rule on March 2, 2012 in Vol. 38, No. 9 of the F.A.W.

4. The revision date of Form DH-MQA 1215, “Institutional Permit Application and Information” incorporated by reference in subsection (3) will be updated to have an effective date of August 2012.

5. The revision date of Form DH-MQA 1218, “Nuclear Pharmacy Permit Application and Information” incorporated by reference in subsection (4) will be updated to have an effective date of August 2012.

6. The revision date of Form DH-MQA 1220, “Special Pharmacy Permit Application and Information” listed in subsection (5) and subsection (6) will be updated to have an effective date of August 2012.

7. The revision date of Form DH-MQA 1217, “Non-Resident Pharmacy Permit Application and Information” incorporated by reference in subsection (7) will be updated to have an effective date of August 2012.

8. The title of the form listed in paragraph (3)(b) and (5)(c) will be changed to Form DH-MQA 1184 “Change of Consultant Pharmacist of Record,” effective December 2010.

9. The language “which is incorporated by reference herein” will be removed from paragraphs (4)(b), (5)(b), (5)(c), (6), and (6)(b).

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Mark Whitten, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254